Investing
J&J's Earnings Win Muted By Currency Impact (JNJ)
Published:
Last Updated:
DJIA component Johnson & Johnson (NYSE: JNJ) has come out with earnings slightly ahead of estimates. The medical and consumer products giant posted $1.15 EPS vs $1.11 estimates and revenues were down 7.4% to $15.2 billion vs. 15.02 billion estimates. Currency was another drag on the company.
As far as the impact of currency, this was sharp. Operational results were down 1.4% and the impact of currency was negative by 6.0%. Operational growth of sales was roughly 3.9%, reflecting a negative currency impact of 11.9%.
Despite the beat on earnings, this marks a 6.7% drop in domestic sales and marks a 8% drop in international sales. Consumer product sales were down 4.5%.
J&J is also backing its annual outlook of $4.45 to $4.55 EPS for 2009. Thomson Reuters has estimates of $4.51.
Shares closed at $57.72 yesterday, and pre-market indications are up over $58.50. Its 52-week trading range is $46.25 to $72.76.
JON C. OGG
JULY 14, 2009
Are You Ahead, or Behind on Retirement?
If you’re one of the over 4 Million Americans set to retire this year, you may want to pay attention. Many people have worked their whole lives preparing to retire without ever knowing the answer to the most important question: am I ahead, or behind on my goals?
Don’t make the same mistake. It’s an easy question to answer. A quick conversation with a financial advisor can help you unpack your savings, spending, and goals for your money. With Zoe Financial’s free matching tool, you can connect with trusted financial advisors in minutes.
Why wait? Click here to get started today!
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.